Tracy Butler
Overview
Explore the profile of Tracy Butler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
2031
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Butler T, Tey S, Galvin J, Perry G, Bowen R, Atwood C
J Alzheimers Dis
. 2024 Sep;
101(3):705-713.
PMID: 39240636
The increase in the incidence of dementia over the last century correlates strongly with the increases in post-reproductive lifespan during this time. As post-reproductive lifespan continues to increase it is...
2.
Biskaduros A, Glodzik L, Saint Louis L, Rusinek H, Pirraglia E, Osorio R, et al.
Alzheimers Dement
. 2024 May;
20(7):4389-4400.
PMID: 38808676
Introduction: We examined whether hypertension (HTN) was associated with Alzheimer's disease-related biomarkers in cerebrospinal fluid (CSF) and how changes in blood pressure (BP) related to changes in CSF biomarkers over...
3.
Haghdel A, Smith N, Glodzik L, Li Y, Wang X, Crowder T, et al.
Alzheimer Dis Assoc Disord
. 2024 May;
38(2):107-111.
PMID: 38752577
Background: Blood-brain barrier (BBB) dysfunction is emerging as an important pathophysiologic factor in Alzheimer disease (AD). Cerebrospinal fluid (CSF) platelet-derived growth factor receptor-β (PDGFRβ) is a biomarker of BBB pericyte...
4.
Butler T, Wang X, Chiang G, Xi K, Niogi S, Glodzik L, et al.
J Alzheimers Dis
. 2024 Apr;
99(1):307-319.
PMID: 38669537
Background: Alzheimer's disease (AD) pathology is considered to begin in the brainstem, and cerebral microglia are known to play a critical role in AD pathogenesis, yet little is known about...
5.
Butler T, Schubert J, Karakatsanis N, Hugh Wang X, Xi K, Kang Y, et al.
Neurotrauma Rep
. 2024 Apr;
5(1):359-366.
PMID: 38655117
Brain fluid clearance by pathways including the recently described paravascular glymphatic system is a critical homeostatic mechanism by which metabolic products, toxins, and other wastes are removed from the brain....
6.
Mehta N, Wang X, Keil S, Xi K, Zhou L, Lee K, et al.
Fluids Barriers CNS
. 2024 Apr;
21(1):30.
PMID: 38566110
Background: Reduced clearance of cerebrospinal fluid (CSF) has been suggested as a pathological feature of Alzheimer's disease (AD). With extensive documentation in non-human mammals and contradictory human neuroimaging data it...
7.
Kim R, Zhou L, Li Y, Krieger A, Nordvig A, Butler T, et al.
J Neurol Sci
. 2024 Feb;
458:122927.
PMID: 38341949
Background: Impaired sleep is commonly associated with Alzheimer's disease (AD), although the underlying mechanisms remain unclear. Furthermore, the moderating effects of sleep-affecting medications, which have been linked to AD pathology,...
8.
9.
Schaefer M, Ahrens E, Butler T
JACC Clin Electrophysiol
. 2023 Jun;
9(6):871.
PMID: 37380320
No abstract available.
10.
Mehta N, Zhou L, Li Y, McIntire L, Nordvig A, Butler T, et al.
Sci Rep
. 2023 May;
13(1):8847.
PMID: 37258519
Neuroinflammation is believed to be a key process in Alzheimer's disease (AD) pathogenesis. Recently, the neutrophil-to-lymphocyte (NLR) and lymphocyte-to-monocyte ratios (LMR) have been proposed to be useful peripheral markers of...